By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Zenobia Therapeutics, Inc. 

505 Coast Boulevard South
Suite 111
La Jolla  California  92037  U.S.A.
Phone: 858-926-5780 Fax: n/a



Company News
Zenobia Therapeutics, Inc. Announce a Partnership With the Alzheimer's Drug Discovery Foundation 8/14/2012 9:41:07 AM
Zenobia Therapeutics, Inc. and BioBlocks, Inc. Announce Sale of a Joint Fragment Library Ideal for Screening by All Popular Methods 5/7/2012 11:20:40 AM
Zenobia Therapeutics, Inc. Enters Into a Research Collaboration With Lundbeck Inc. for the Parkinson's Disease Target LRRK2 12/16/2010 6:45:37 AM
Zenobia Therapeutics, Inc. Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals, Inc. 4/14/2009 9:10:51 AM
Zenobia Therapeutics, Inc. Announces Sale of Commercial Fragment Library Ideal for Crystallographic, NMR and SPR Screening 3/2/2009 11:13:56 AM
Zenobia Therapeutics, Inc. Receives The Michael J. Fox Foundation for Parkinson's Research Award for Work on PD-implicated Protein LRRK2 7/29/2008 7:54:42 AM
Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company 7/21/2008 6:23:12 AM